Back to search
Erythropoietic Protoporphyria (EPP)
Clinical trial pipeline · Data from ClinicalTrials.gov
See which Erythropoietic Protoporphyria (EPP) trials you may qualify forClinical trial pipeline · Data from ClinicalTrials.gov
See which Erythropoietic Protoporphyria (EPP) trials you may qualify forThe purpose of this study is to collect information about the effects of EPP/XLP in adults and adolescents. This is an observational study in which participants…
The objective of this protocol is to conduct a longitudinal multidisciplinary investigation of the human porphyrias including the natural history, morbidity, pr…
To evaluate the long-term safety and tolerability of oral dersimelagon.
To investigate the efficacy of MT-7117 on time to onset and severity of first prodromal symptoms (burning, tingling, itching, or stinging) associated with sunli…
The goal of this clinical trial is to learn if bitopertin works and is safe to treat EPP or XLP in participants 12 years or older. The main questions it aims to…
The purpose of this study is to evaluate the concentration of afamelanotide in serum after the administration of afamelanotide in adolescent and adult EPP patie…